MyoKardia

MyoKardia

World Rank (Jan-05-2024)

3,600

World Rank (Jul-30-2023)

3,600

World Rank (Jan-07-2022)

3,600

World Rank (Jan-01-2021)

3,600

Headquarters Country

Headquarters City/State

World Region

World Subregion

Northern America

Business Sector

HealthCare Products

Company Website

Company Profile

MyoKardia is a Transformative Therapies company. It is applying a precision medicine approach to develop therapeutic candidates for patient populations with shared characteristics such as causal genetic mutations or disease subtypes. The headquarters is in USA.

Bristol Myers Squibb acquired MyoKardia for 13.1 Billion USD in Nov-2020.

Facts About Company

Bristol Myers Squibb acquired MyoKardia for 13.1 Billion USD in Nov-2020

IPO Year

2015

Stock Exchange

Company SubCategory

Top Healthcare Companies in USA

Share